The Epidemiology of Ground Glass Opacity Lung Adenocarcinoma : A Network-Based Cumulative Meta-Analysis

Copyright © 2020 Li, Ren, Wang, He, Song, Chen and Xu..

Introduction: Due to the introduction of low-dose computed tomography (CT) and screening procedures, the proportion of early-stage lung cancer with ground glass opacity (GGO) manifestation is increasing in clinical practice. However, its epidemiological characteristics is still not fully investigated. Methods: We retrieved all solitary GGO adenocarcinoma lung cancer (ADLC) on the PubMed, Cochrane Library, and Embase databases until January 1, 2019 and extracted the general information to perform the meta-analysis, mainly focusing on age, gender, and smoking status. Results: A total of 8,793 solitary GGO ADLC patients from 53 studies were included in this analysis. The final pooled analysis showed that the female proportion, average diagnosis age, and non-smoking proportion of solitary GGO ADLC was 0.62 (95% CI, 0.60-0.64), 56.97 (95% CI, 54.56-59.37), and 0.72 (95% CI, 0.66-0.77), respectively. The cumulative meta-analysis and meta-trend analysis confirmed that the average age at diagnosis has been decreasing while the non-smoking proportion significantly increased in the past two decades. Conclusions: From our epidemiological analysis, it demonstrates that the clinical characteristics of GGO lung cancer patients may be out of the high-risk factors. Therefore, we propose to reconsider the risk assessment and current lung cancer screening criteria.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:10

Enthalten in:

Frontiers in oncology - 10(2020) vom: 05., Seite 1059

Sprache:

Englisch

Beteiligte Personen:

Li, Xiongfei [VerfasserIn]
Ren, Fan [VerfasserIn]
Wang, Shuhang [VerfasserIn]
He, Zhicheng [VerfasserIn]
Song, Zuoqing [VerfasserIn]
Chen, Jun [VerfasserIn]
Xu, Song [VerfasserIn]

Links:

Volltext

Themen:

Cumulative meta-analysis
Epidemiological trends
Ground glass opacity
Lung adenocarcinoma
Lung cancer screening criteria
Systematic Review

Anmerkungen:

Date Revised 28.09.2020

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.3389/fonc.2020.01059

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM313681414